[Warning against the use of diphenoxylate (Reasec) by children with diarrhea].

B E van den Boezem

Home/Archive/PubMed

PubMed · 6866142

[Warning against the use of diphenoxylate (Reasec) by children with diarrhea].

B E van den Boezem

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Antidiarrheals Diarrhea, Infantile Diphenoxylate Female Humans Infant Intestinal Absorption Isonipecotic Acids Nervous System Diseases Case Reports English Abstract Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

B E van den Boezem. 1983-05-21. [Warning against the use of diphenoxylate (Reasec) by children with diarrhea].. https://pubmed.ncbi.nlm.nih.gov/6866142/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Management of diarrhea induced by tumors or cancer therapy.

Diarrhea is a common event in the clinical history of cancer patients. It can be caused by the presence of tumor or it can be a side effect of treatment. The latter problem is occurring more often because new drugs (CPT-11) or drug combinations (fluorouracil plus interferon or leucovorin) have diarrhea as the dose-limiting toxicity. The clinical use of octreotide, a long-acting somatostatin analogue, seemed to demonstrate an improvement in most diarrheal states induced by tumors (endocrine tumors) or by treatments (short bowel syndrome; chemotherapy-induced diarrhea).

Antidiarrheals↗

PubMed1995

[Sandostatin in the treatment of diarrhea of different origins].

Antidiarrheal action of sandostatin (octreotide) was studied in dumping syndrome, diabetic enteropathy, short-bowel syndrome, Crohn's disease and ulcerative colitis. Sandostatin proved effective in diarrhea of secretory, motor and osmotic origin. Dumping syndrome, diabetic enteropathy, Crohn's disease and short-bowel syndrome responded completely. In ulcerative colitis the effect was paradoxical: intensive diarrhea discontinued, but moderate diarrhea became more intensive. Sandostatin indications in ulcerative colitis should receive further investigations.

Antidiarrheals↗

PubMed1992

Determination of Zy 17617B in plasma by solid-phase extraction and liquid chromatography with automated pre-column exchange.

An automated chromatographic system, combining solid-phase extraction and automated pre-column exchange, is described for the routine determination of Zy 17617B at the pmol/ml level in human plasma. The sample extraction and elution onto the analytical column were performed automatically and concomitantly using a conventional liquid chromatographic apparatus equipped with a Merck OSP-2 on-line sample preparator. Validation data demonstrate the reliability of the method.

Antidiarrheals↗